［1］ American Academy of Pediatrics Committee on Drugs.Neonatal drug withdrawal. ＦPediatrics 1998; 101: 1079～1088.
［2］ Substance Abuse and Mental Health Services Administration,Office of Applied Studies, Preliminary results from the 1996 national household servey on drug abuse, Washington DC: US Dept of Health and Human Service. 1997
［3］ Milhorn HT, Pharmacologic www.youerw.com management of acute abstinence syndroms. Am Fam Physician 1992; 45: 231～238.
［4］ Khalsa JH, Gfroerer J, Epidemiology and health consequences of drug among pregnant woman,Semin Perinatol 1991; 15: 265～270.
［5］ Bean X, Maternal substance abuse. In. Taeusch HW, Ballard RA, Avery ME. eds. Schaffer and Avery's Disease of the newborn, 6th ed. Philadelphia: Saunders. 1991: 243～253.
［6］ Kiegman RM, Behrman RE. Substance abuse and withdrawals. In. Behrman RE, Kliegman RM, Nelson WE, et al. Eds. Nelson Textbook of Pediatrics, 14 thed. Philadelphia: saunders. 1992: 490～492.
［7］ Rosenberg AA, Battaglia FC. Infants of mothers who abuse drugs. In. Hathaway WE, Groothuis JR, Hay, Jr WW, et al. Current Pediatric Diagnosis & Treatment, 10th ed. Norwalk Connecticut, California: Appleton & Lange. 1991: 96～98.
［8］ Pildes RS, Srinivasan G. Infants of drug-dependent mothers. In. Gellis SS, Kagan BM. eds. Current Pediatric Therapy, Vol 13, Philadelphia: Saunders. 1990: 702～707.
［9］ Ostrea EM. Infants of drug-dependent mothers. In. Burg FD, Ingelfinger JR, Wald ER. eds. Current Pediatric Therapy, Vol 14. 1993: 800～801.
［10］ Committee on Substance Abuse, Academy of Pediatrics. Substance abuse, Pediatrics 1990; 86: 639～642.
［11］ Finnegan LP, Neonatal abstinece. In. Nelson NM. Ed. Current Therapy in Neonatal-Perinatal Medicine. Toronto: BC Decker. 1985: 262～270.
［12］ Finnegan L, Kaltenbach K, Weiner S, et al. Neonatal cocaine exposure assessment of risk scale. Pediatr Res 1990 27: 10A.
［13］ Ryan RM, Wagner CL, Schultz JM, et al. Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr 1994; 125:435～440.
［14］ Horowitz RM, Drug use in pregnancy: to test, to tell: Legal implications for the physician. Semin Perinatol 1991; 15: 324～330.
［15］ King TA, Perlman JM, Laptook AR, ed. Neurologic manifestations of in utero cocaine exposure in near-term and term infants. Pediatrics 1995; 96: 259～269.
［16］ Napiorkowski B, Lester BM, Freier MC, et al. Effects of in utero substances exposure on infant neurobehavior, Pediatrics 1996; 98: 71～75.
［17］ Tromick EZ, Frand DA, Cabral H, et al. Late dose-responds of prenatal cocaine exposure on newborn neurobehavioral performance, Pediatrics 1996; 98: 76～83.
［18］ Mayer LC, granger RH, Frank M, et al. Neurobehavioral Profiles of neonates exposed to cocaine prenatally. Pediatrics 1993; 91: 778～783.
［19］ Singer L, Arendt R, Minnes S. Neurodevelopmental effects of cocaine. Clin Perinatol 1993; 20: 245～262.
［20］ Zuckerman B, Bresnahan K. Developmental and behavioral consequences of drug and alcohol exposurs. Pediatr Chin North Am 1991; 38: 1387～1406.
［21］ Behnke M, Eyler FD, Conlon M, et al. Incidence and description of structual brain abnormalities in newborn exposed to cocaine. J Pediatr 1998; 132: 291～294.
［22］ Lipsitz PJ. Aproposed narcotic withdrawal score for use with newborn infants. a pragmatic evaluation of its efficacy. Clin Pediatr 1975; 14: 592～594. ［23］ Wijburg FA, Kleine MJ, Fleury P, et al. Morphine as an anti-epileptic drug in neonatal abstinence syndrome. Acta Pediatr Scand. 1991; 80: 875～877.
［24］ Anand KJ, Amold JH. Opioid tolerance and dependence in infants and children. Crit Care Med 1994; 22: 334～342.
［25］ Tobias JD, Schieien CL, Haun SE. Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive care unit patients. Crit Care Med 1990; 18: 1292～1293.
［26］ Baumgartner GR, Rowen RC. Transdermal clonidine versus chlordiazepam in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 1991; 84: 312～321.
［27］ Ashery R, Robertson E, Kumpfer KL. eds. Drug Abuse Prevention Trough Family Intervention. Rockville, MD: NIH Pub. 1998.
［28］ Johnson JL, Leff M. Children of substance abusers: Overview of research findings. Pediatrics 1999; 103: 1085～1099.
［29］ Werner MJ, Joffe A, Graham AV. Screening, early identification, and office-based intervention with children and youth living in substance-abusing families. Pediatrics 1999; 103: 1099～1112.
［30］ Kumpfer KL. Outcome measures of interventions in the study of children of substance-abusing parents. Pediatrics 1999; 103: 1128～1144.